Your company account is blocked and you cannot place orders. If you have questions, please contact your company administrator.

(S)-4-[(S)-2-((S)-2-{(S)-2-[(S)-2-Acetylamino-3-(4-phosphonooxy-phenyl)-propionylamino]-4-methyl-pentanoylamino}-6-amino-hexanoylamino)-4-carbamoyl-butyrylamino]-4-((S)-1-carbamoyl-2-hydroxy-ethylcarbamoyl)-butyric acid

ID: ALA436427

PubChem CID: 24768168

Max Phase: Preclinical

Molecular Formula: C36H58N9O15P

Molecular Weight: 887.88

Molecule Type: Protein

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(N)=O

Standard InChI:  InChI=1S/C36H58N9O15P/c1-19(2)16-26(44-36(56)27(40-20(3)47)17-21-7-9-22(10-8-21)60-61(57,58)59)35(55)41-23(6-4-5-15-37)32(52)42-24(11-13-29(38)48)33(53)43-25(12-14-30(49)50)34(54)45-28(18-46)31(39)51/h7-10,19,23-28,46H,4-6,11-18,37H2,1-3H3,(H2,38,48)(H2,39,51)(H,40,47)(H,41,55)(H,42,52)(H,43,53)(H,44,56)(H,45,54)(H,49,50)(H2,57,58,59)/t23-,24-,25-,26-,27-,28-/m0/s1

Standard InChI Key:  BFECKAKSTGTSRV-QUQVWLGBSA-N

Molfile:  

     RDKit          2D

 61 61  0  0  1  0  0  0  0  0999 V2000
   -2.3625    0.0250    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    4.0792   -2.8667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9292   -3.2792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5167   -3.2792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3792   -2.8667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2292   -3.2792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2417   -2.8667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6500   -2.8667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.9625   -3.2792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9500   -2.8667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.0917   -3.2792    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.8000   -3.2792    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3667   -3.2792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6792   -2.8667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2167   -2.8667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5000   -3.2792    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.8125   -2.8667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6625   -3.2792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5125   -2.8667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5000   -4.1042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6458   -0.3875    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.3792   -5.3417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5167   -0.8000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9583    0.7458    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.9292   -4.1042    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.0792   -2.0375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.5167   -4.1042    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.2292   -4.1042    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.3792   -2.0375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2167   -2.0375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6792   -2.0375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3667   -4.1042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2167   -4.5167    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.0917   -5.7542    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.2417   -0.3875    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.6625   -4.1042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8125   -2.0375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0833    0.4375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7750   -0.6875    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.3917   -3.2792    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.3792   -4.5167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5167   -1.6250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9333   -0.8000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6625   -5.7542    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.5000   -1.6250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8125   -0.3875    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.9625   -4.1042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2208   -2.0375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5000   -0.8000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9333   -1.6250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2208   -0.3875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9500    0.4458    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.6792   -4.5167    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.0792   -4.5167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2125   -4.5167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5125   -2.0375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9500   -0.3875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2292   -1.6250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2292   -0.8000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8000   -4.1042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0792   -5.3417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2 13  1  0
  3 15  1  0
  4 17  1  0
  5 18  1  0
  6 19  1  0
  7  4  1  0
  8  3  1  0
  9  7  1  0
 10  6  1  0
 11  5  1  0
 12  2  1  0
 13  8  1  0
 14  9  1  0
 15 30  1  1
 16 15  1  0
 17 11  1  0
 18 10  1  0
 19 12  1  0
 20 16  1  0
 21  1  1  0
 22 41  1  0
 23 42  1  0
 24  1  2  0
 25  3  2  0
 26  2  2  0
 27  4  2  0
 28  6  2  0
 29  5  2  0
 30 45  1  0
 31 14  2  0
 13 32  1  6
 33 20  2  0
 34 22  2  0
 35 23  2  0
 18 36  1  6
 17 37  1  1
 38  1  1  0
 39  1  1  0
 40 14  1  0
 41 36  1  0
 42 37  1  0
 43 21  1  0
 44 22  1  0
 45 49  2  0
 46 23  1  0
  9 47  1  6
 48 50  2  0
 49 51  1  0
 50 43  1  0
 51 43  2  0
 52 57  1  0
 53 47  1  0
 54 32  1  0
 55 20  1  0
 19 56  1  1
 57 59  1  0
 58 56  1  0
 59 58  1  0
 60 54  1  0
 61 54  1  0
 48 45  1  0
M  END

Alternative Forms

  1. Parent:

    ALA436427

    Y(p)LKQES

Associated Targets(Human)

STAT3 Tchem Signal transducer and activator of transcription 3 (3313 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: ProteinTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Calculated Properties

Molecular Weight: 887.88Molecular Weight (Monoisotopic): 887.3790AlogP: -3.59#Rotatable Bonds: 29
Polar Surface Area: 411.09Molecular Species: ZWITTERIONHBA: 13HBD: 13
#RO5 Violations: 3HBA (Lipinski): 24HBD (Lipinski): 16#RO5 Violations (Lipinski): 3
CX Acidic pKa: 1.79CX Basic pKa: 16.03CX LogP: -6.10CX LogD: -10.08
Aromatic Rings: 1Heavy Atoms: 61QED Weighted: 0.03Np Likeness Score: 0.31

References

1. Ren Z, Cabell LA, Schaefer TS, McMurray JS..  (2003)  Identification of a high-affinity phosphopeptide inhibitor of Stat3.,  13  (4): [PMID:12639546] [10.1016/s0960-894x(02)01050-8]
2. Mandal, Pijus K PK and 9 more authors.  2009-04-23  Conformationally constrained peptidomimetic inhibitors of signal transducer and activator of transcription. 3: Evaluation and molecular modeling.  [PMID:19334714]
3. Mandal, Pijus K; Ren, Zhiyong; Chen, Xiaomin; Xiong, Chiyi and McMurray, John S.  2009-10-08  Structure-affinity relationships of glutamine mimics incorporated into phosphopeptides targeted to the SH2 domain of signal transducer and activator of transcription 3.  [PMID:19728728]
4. Ioannidis, Stephanos S and 20 more authors.  2011-01-13  Discovery of 5-chloro-N2-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-N4-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine (AZD1480) as a novel inhibitor of the Jak/Stat pathway.  [PMID:21138246]
5. Mandal, Pijus K and 10 more authors.  2011-05-26  Potent and selective phosphopeptide mimetic prodrugs targeted to the Src homology 2 (SH2) domain of signal transducer and activator of transcription 3.  [PMID:21486047]
6. Ren, Xiaomei X and 8 more authors.  2010-12-09  Identification of Niclosamide as a New Small-Molecule Inhibitor of the STAT3 Signaling Pathway.  [PMID:24900231]
7. Haftchenary, Sina S and 15 more authors.  2013-11-14  Potent Targeting of the STAT3 Protein in Brain Cancer Stem Cells: A Promising Route for Treating Glioblastoma.  [PMID:24900612]
8. LaPorte, Matthew G and 11 more authors.  2014-11-01  2-Guanidinoquinazolines as new inhibitors of the STAT3 pathway.  [PMID:25288188]
9. Miklossy, Gabriella G and 15 more authors.  2015-10-08  Hirsutinolide Series Inhibit Stat3 Activity, Alter GCN1, MAP1B, Hsp105, G6PD, Vimentin, TrxR1, and Importin α-2 Expression, and Induce Antitumor Effects against Human Glioma.  [PMID:26331426]
10. Löcken, Hauke H, Clamor, Cinzia C and Müller, Klaus K.  2018-07-27  Napabucasin and Related Heterocycle-Fused Naphthoquinones as STAT3 Inhibitors with Antiproliferative Activity against Cancer Cells.  [PMID:30003778]
11. Huang, Wei W and 8 more authors.  2018-09-05  Small-molecule compounds targeting the STAT3 DNA-binding domain suppress survival of cisplatin-resistant human ovarian cancer cells by inducing apoptosis.  [PMID:30145375]
12. Chen, Shao-Ru SR and 7 more authors.  2018-10-01  Andrographolide derivative as STAT3 inhibitor that protects acute liver damage in mice.  [PMID:30228000]
13. Li, Chungen C and 8 more authors.  2019-01-15  A novel series of napabucasin derivatives as orally active inhibitors of signal transducer and activator of transcription 3 (STAT3).  [PMID:30472602]
14. Zhou, Haibin and 18 more authors.  2019-12-26  Structure-Based Discovery of SD-36 as a Potent, Selective, and Efficacious PROTAC Degrader of STAT3 Protein.  [PMID:31747516]
15. Kaoud, Tamer S and 7 more authors.  2020-01-15  NO-releasing STAT3 inhibitors suppress BRAF-mutant melanoma growth.  [PMID:31784187]
16. Cerulli, Robert A and 6 more authors.  2020-06-15  Cytosolic delivery of peptidic STAT3 SH2 domain inhibitors.  [PMID:32503696]
17. Brotherton-Pleiss, Christine and 13 more authors.  2021-01-14  Discovery of Novel Azetidine Amides as Potent Small-Molecule STAT3 Inhibitors.  [PMID:33352047]

Source